Protalix BioTherapeutics Set to Present at Key Investment Conference
![Protalix BioTherapeutics Set to Present at Key Investment Conference](https://investorshangout.com/images/blog/ihnews-Protalix%20BioTherapeutics%20Set%20to%20Present%20at%20Key%20Investment%20Conference.jpg)
Protalix BioTherapeutics to Present at Annual Global Conference
Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company known for its focus on developing and producing innovative therapeutic proteins, is preparing to present at a major investment conference. Dror Bashan, the President and CEO of Protalix, is set to represent the company during the H.C. Wainwright 26th Annual Global Investment Conference.
Conference Details and Engagements
This key event is scheduled for September 9–11, where industry leaders come together to discuss advancements in the field and explore potential investment opportunities.
Mr. Bashan will be presenting on September 11 at 12:30 p.m. The presentation is expected to provide insights into Protalix's innovative approaches and product pipeline. In addition to the presentation, company management will be engaging in one-on-one meetings with registered investors throughout the conference, allowing for deeper discussions about their projects and financial health.
About Protalix BioTherapeutics, Inc.
Protalix stands out in the biopharmaceutical industry for its unique approach to producing therapeutic proteins via its proprietary ProCellEx plant cell-based expression system. This pioneering method has allowed it to become the first company to receive FDA approval for a protein manufactured through plant cell technology. One of its notable achievements includes the licensing of taliglucerase alfa, aimed at treating Gaucher disease, to Pfizer Inc.
Innovative Products in Development
Elfabrio, Protalix’s latest product, received dual approvals from both the FDA and EMA in May 2023, marking a significant milestone for the company. Furthermore, Protalix has partnered with Chiesi Farmaceutici S.p.A. to enhance the global reach and efficacy of Elfabrio.
Pipeline and Future Aspirations
The company's development pipeline showcases a range of proprietary recombinant therapeutic proteins that address significant pharmaceutical market needs. This includes PRX–115, designed as a PEGylated uricase for managing uncontrolled gout and PRX–119, which targets NETs-related diseases with a long-acting DNase I formulation.
Investor Relations
For inquiries, investors can reach out to Mike Moyer, Managing Director at LifeSci Advisors. His contact number is +1-617-308-4306. Protalix remains committed to transparency and regularly updates their stakeholders on developments.
Frequently Asked Questions
What is Protalix BioTherapeutics known for?
Protalix BioTherapeutics focuses on developing and commercializing recombinant therapeutic proteins using its ProCellEx plant cell-based system.
Who will present at the investment conference?
Dror Bashan, the President and CEO of Protalix, is set to present at the conference.
When is the conference being held?
The H.C. Wainwright 26th Annual Global Investment Conference is scheduled for September 9–11.
What recent product approvals has Protalix achieved?
Elfabrio was recently approved by the FDA and EMA, indicating Protalix’s growing footprint in the biopharmaceutical market.
How can investors contact Protalix for more information?
Investors can contact Mike Moyer at LifeSci Advisors at +1-617-308-4306 for inquiries and further information.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Related Articles
- Survey Highlights Employee Relations as Business Complexity Factor
- Service World Expo 2024: Key Insights and Exciting Trends
- Critical Metals Corp. Launches Drilling at Tanbreez Project
- Cadar Appoints Ralph Simons as CEO to Lead Fine Jewelry Brand
- Guidehouse Welcomes Patrick Spoletini as Growth Leader in Health
- NKF Launches Essential Online Education for Kidney Disease
- Acer Unveils Swift Go 14 AI and Swift 14 AI Laptops Boosting Productivity
- Flexential's Innovative Growth Strategies Set for 2024 Success
- Vanguard Lowers Asset Minimums for Enhanced Digital Advice
- Cetaphil Unveils Gentle Exfoliating Line Featuring Katie Fang
- Market Volatility: Recession Fears Impact Investor Confidence
- Acer Unveils TravelMate P6 14 AI: A Game Changer in Laptops
- Critical Metals Launches Major Drilling Program at Tanbreez
- Saudi Arabia's Stock Market Overview: Tadawul Performance Insights
- Ongoing Ozempic Shortages Impacting Europe into Q4 2024
- Stocks Remain Resilient Amid Market Volatility: Insights
- Wells Fargo Expands 'Signature Picks' with Microsoft and Adobe
- SSI Raises $1 Billion to Develop Advanced AI Safety Solutions
- Global Market Index Sees Declining Returns for Investors
- Catchlight Launches Beta for Innovative Lead Routing Model
- Montway Auto Transport Celebrated as 2024 MOTOR Top 20 Winner
- GOOD GOOD Launches Innovative No Added Sugar Vegan Lemon Curd
- Solid Waste Management Market Expected to Hit $440 Billion by 2032
- Automated Liquid Handling Technologies Set for Major Growth
- The Dermatology Specialists Launch 50th Location with Free Screenings
Recent Articles
- Big Wave Systems Partners with CMS for Health Insurance Support
- Central Florida Hospital Integrates Daxor’s BVA-100™ for Care
- Arthrex Unveils Enhanced Online Learning Tool for Patients
- Providence Treatment Expands Services as Dual Diagnosis Provider
- Super Micro Computer Faces Downgrade: Analyzing Market Impact
- Nordstrom Founders Propose $23 Per Share Takeover Bid
- Satellite Communication Market Set to Reach USD 188.94 Billion
- Survey Reveals AI is Key Focus for Healthcare Leaders
- Psyence Biomed Partners with PsyLabs for Psilocybin Research
- Pan Global Expands Soil Geochemistry Anomaly at Bravo Target
- Ciena Corp Reports Impressive Q3 Earnings and Revenue Growth
- Cardano vs. Polkadot: Who Will Dominate Blockchain Governance?
- Leslie's, Inc. Engages at Goldman Sachs Global Retailing Event
- Brain Aneurysm Foundation Unveils 2024 Research Grant Winners
- HARIBO Launches Fall Edition Goldbears and Halloween Treats
- Robertshaw Unveils 780U Series for Universal Ignition Solutions
- Waterdrop Inc. Reports Q2 2024 Financial Results and Dividend
- Dollar Tree Adjusts Annual Forecast Amid Weak Demand Challenges
- BC.GAME Unveils Brand Transformation for Enhanced Experience
- Vista Energy's $1.1 Billion Investment in Argentina's Shale
- Star Entertainment Faces Challenges While Finalizing Results
- Investing in Dividend Stocks: Opportunities for September Success
- Global Burn Care Market Expected to Reach USD 4.88 Billion
- Baseus Showcases Innovative Products at 2024 IFA Expo
- Appian Champions Rising Golf Star Marta Sanz Barrio